ELEVANCE HEALTH ($ELV) posted quarterly earnings results on Tuesday, April 22nd. The company reported earnings of $11.97 per share, beating estimates of $11.50 by $0.47. The company also reported revenue of $48,765,000,000, beating estimates of $46,752,968,680 by $2,012,031,320.
You can see Quiver Quantitative's $ELV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ELEVANCE HEALTH Insider Trading Activity
ELEVANCE HEALTH insiders have traded $ELV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ELV stock by insiders over the last 6 months:
- CHARLES MORGAN JR KENDRICK (EVP & President, Commercial) sold 3,504 shares for an estimated $1,388,635
- RONALD W PENCZEK (CAO & Controller) sold 443 shares for an estimated $183,902
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ELEVANCE HEALTH Hedge Fund Activity
We have seen 642 institutional investors add shares of ELEVANCE HEALTH stock to their portfolio, and 934 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,426,019 shares (-52.5%) from their portfolio in Q4 2024, for an estimated $894,958,409
- WELLINGTON MANAGEMENT GROUP LLP added 1,893,947 shares (+42.5%) to their portfolio in Q4 2024, for an estimated $698,677,048
- AMERIPRISE FINANCIAL INC removed 1,872,364 shares (-49.4%) from their portfolio in Q4 2024, for an estimated $690,715,079
- HARRIS ASSOCIATES L P added 1,821,284 shares (+inf%) to their portfolio in Q4 2024, for an estimated $671,871,667
- ORBIS ALLAN GRAY LTD added 1,264,048 shares (+139.7%) to their portfolio in Q4 2024, for an estimated $466,307,307
- FIRST EAGLE INVESTMENT MANAGEMENT, LLC added 1,039,612 shares (+47.6%) to their portfolio in Q4 2024, for an estimated $383,512,866
- JPMORGAN CHASE & CO removed 942,104 shares (-37.3%) from their portfolio in Q4 2024, for an estimated $347,542,165
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ELEVANCE HEALTH Government Contracts
We have seen $310,181,272 of award payments to $ELV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PART A/PART B MEDICARE ADMINISTRATIVE CONTRACTOR (MAC) JURISDICTION K (JK): $129,249,324
- J6 A/B MAC SERVICES: $92,370,394
- NEXT GENERATION DESKTOP IGF::OT::IGF: $67,967,911
- SPARC WILL BE THE MAJOR CONTRACT VEHICLE FOR CMS IT SYSTEMS AND SUPPORT HHS OPDIVS CAN ALSO MAKE USE OF SPA...: $9,953,079
- INNOVATION PAYMENT CONTRACTOR (IPC) CONTRACT AWARD: $4,219,631
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ELEVANCE HEALTH Congressional Stock Trading
Members of Congress have traded $ELV stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ELV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JARED MOSKOWITZ has traded it 4 times. They made 1 purchase worth up to $15,000 on 11/08 and 3 sales worth up to $45,000 on 03/10.
- REPRESENTATIVE JEFFERSON SHREVE purchased up to $50,000 on 02/24.
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 01/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ELEVANCE HEALTH Analyst Ratings
Wall Street analysts have issued reports on $ELV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Bernstein issued a "Outperform" rating on 03/28/2025
To track analyst ratings and price targets for ELEVANCE HEALTH, check out Quiver Quantitative's $ELV forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
